CVS Health (CVS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some ...

Analysts have recently evaluated CVS Health and provided 12-month price targets. The average target is $74.12, accompanied by ...

CVS faces pressures from rising medical costs, but promising guidance, stable finances, and low valuations suggest strong ...

CVS Health announced a new CFO and chief medical officer. The company's biggest news, though, could be that it's off to a relatively good start in 2025. CVS Health announced that Brian Newman will ...

CVS Health stock (NYSE: CVS) has become one of the top ... These external factors add considerable risks to the market environment. See our analysis here on the macro picture.

An in-depth analysis of recent analyst actions ... the company may face hurdles in achieving optimal financial performance. Return on Assets (ROA): CVS Health's ROA stands out, surpassing industry ...

In the most recent trading session, CVS Health (CVS) closed at $68.07, indicating a +0.13% shift from the previous trading day. While many stocks in the S&P 500 ETF posted dismal performance in ...

In November 2024, CVS Health appointed Prem Shah as the Group President, responsible for the operational performance across ...

CVS Health (CVS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.